Biopharma growth in Singapore sees Avantor's investment
Singapore, May 5, 2022 – – Avantor, Inc. (NYSE: AVTR) today announced it will create a new manufacturing and distribution Hub in Singapore to capture the growth of the biopharma business, by integrating its existing distribution facility with new manufacturing operations.
Avantor is a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries.
The new Hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year.
Avantor announced it will create a new Manufacturing and Distribution Hub in Singapore by integrating its existing distribution facility with new manufacturing operations.
Biopharma facility
“The Singapore Manufacturing and Distribution Hub will enable Avantor to better serve the fast-growing Asia Pacific Biopharma market by facilitating shorter lead times, enhancing supply chain security and increasing capacity in the region,” says Christophe Couturier, Executive Vice President, AMEA, Avantor.
“The Hub will boost regional innovation and serve as an industry benchmark for Singapore and Asia Pacific’s global quality and regulatory standards, and demonstrates Avantor’s commitment to growing our presence in the region.”
The new Hub will provide a range of services including quality control and inventory management expertise, and feature cGMP manufacturing suites and testing labs for process ingredients and excipients.
About Avantor
Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
“Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve.
“Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world,” says the company’s media release.
(ACN Newswire)